None listed
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: First, between February 2014 and October 2016. adult patients with NAFLD who participated in two previous clinical trials (clinical trial number are KCT 0001480 and KCT 0001588, https://cris.nih.go.kr/cris/index.jsp) performed at a single institution and the baseline patient data will be used in this study. Second, adult consecutive patients (age : 20-75 years) underwent magnetic resonance cholangiopancreatography (MRCP) who were hospitalized for suspicious viral hepatic disorders and biliary disease between February 2014 and October 2016 and performed US simultaneously will be included. The interval between US and MRI should be equal or less than 7 days.
Exclusion criteria
Exclusion criteria: 1) > 7 days interval between MRI PDFF and abdominal ultrasonography 2) age = 19 years 3) primary or secondary hepatic malignancy 4) acute infectious disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sensitivity and specificity for diagnosis of hepatic steatosis using ultrasonography | — |
Secondary
| Measure | Time frame |
|---|---|
| Positive predictive value and negative predictive value for diagnosis of hepatic steatosis using ultrasonography | — |
Countries
Korea, Republic of
Contacts
Hanyang University